Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002667041 | SCV002973393 | pathogenic | Epilepsy, familial adult myoclonic, 5 | 2022-11-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CNTN2-related conditions. This variant is present in population databases (rs779892361, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg140*) in the CNTN2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNTN2 are known to be pathogenic (PMID: 11178983, 23518707). |
Revvity Omics, |
RCV002667041 | SCV003831075 | uncertain significance | Epilepsy, familial adult myoclonic, 5 | 2019-07-08 | criteria provided, single submitter | clinical testing |